Why Has PGx Testing Been So Hard? with Kristine Ashcraft

Pharmacogenetics testing: where are we today? Kristine Ashcraft, CEO, and founder of YouScript, a translational PGX start-up that Invitae recently acquired, joins us on the Beagle to discuss why it has been so hard to get the ball rolling on PGX testing. Kristine, who was called one of the 25 leading voices in precision medicine by BIS Medicine in 2019, lays out a roadmap to the integration of PGX testing into routine clinical care. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit beaglelanded.substack.com